In this article, we will be taking a look at the 13 Most Oversold Healthcare Stocks So Far in 2025. Glaukos Corporation stands seventh among them. Glaukos Corporation (NYSE:GKOS), a leader in ophthalmic pharmaceutical and surgical therapies, continues to expand its presence in glaucoma, corneal disorders, and retinal diseases through innovative “dropless” treatment platforms. Its FDA-approved iDose sustained-release implant delivers continuous glaucoma therapy directly inside the eye, improving patient ad ...